Finally, to date, no tp53 deletion models have been generated in syngeneic zebrafish, precluding large-scale transplantation studies to assess how deletion regulates cancer stem cells and tumor invasion in vivo for a wide array of cancers. This evidence concerns the gene TP53 and neoplasm.